Genmab
Judith Klimovsky is currently serving as EVP & Chief Development Officer at Genmab since February 2017. Prior to this, Judith held various positions at Novartis, including Sr VP Oncology Clinical Development and VP Sr VP, Global Program Head. Judith also has experience working at Merck and BMS in medical director roles. With a degree in MD from the University of Buenos Aires, Judith has a strong background in Oncology Clinical Development.
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.